metoclopramide has been researched along with vindesine in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujieda, K; Ibe, Y; Ito, T; Morinari, H; Naito, S; Okubo, S | 1 |
| Fujii, M; Kiura, K | 1 |
| Endo, K; Ichimura, H; Inoue, S | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
1 trial(s) available for metoclopramide and vindesine
| Article | Year |
|---|---|
[Anti-emetic treatment for patients with non-small cell lung cancer after chemotherapy, usefulness of preventive combination of anti-emetic agents and importance of psychiatric aspect of patients].
Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Drug Therapy, Combination; Female; Granisetron; Humans; Lung Neoplasms; Male; Methylprednisolone; Metoclopramide; Middle Aged; Mitomycin; Personality; Vindesine; Vomiting, Anticipatory | 1999 |
4 other study(ies) available for metoclopramide and vindesine
| Article | Year |
|---|---|
[Antiemetic treatment with metoclopramide and high-dose lorazepam and additional long-term treatment with lorazepam during CDDP administration].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Humans; Lorazepam; Lung Neoplasms; Male; Metoclopramide; Middle Aged; Mitomycin; Mitomycins; Vindesine; Vomiting, Anticipatory | 1988 |
[A case of asthma attack induced by high-dose metoclopramide].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asthma; Carcinoma, Bronchogenic; Cisplatin; Female; Humans; Lung Neoplasms; Metoclopramide; Vindesine | 1986 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |